ΡΑΜΖΑ ΔΙΑΜΑΝΤΗ

MD, MRCOphth, FEBO

ΧΕΙΡΟΥΡΓΟΣ ΟΦΘΑΛΜΙΑΤΡΟΣ

RAMZA DIAMANTI

MD, MRCOphth, FEBO

OPHTHALMOLOGIST SURGEON

  • Ελληνικά

Ramza Diamanti

MD, MRCOphth,  FEBO Ophthalmologist surgeon

DEGREES

in progress

PhD Candidate – University of Athens, Department of Ophthalmology

2012

Diploma/Fellow – European Board of Ophthalmology (FEBO)

2006

Member -The Royal College of Ophthalmologists, UK (MRCOphth I)

2004

Doctor of Medicine – National and Kapodistrian University of Athens Medical School – Athens, Greece

POSITIONS/APPOINTMENTS

2024-Present

Head of Surgical Department, Ophthalmological Institute of Athens (OMMA)

2021-Present

KOL (Key Opinion Leader), Alcon

2020-Present

Ophthalmologist of Veterans Evaluation Services (VES)

2016-Present

Consultant-Cataract Surgery, Alcon Surgical Laboratories

2013-Present

Consultant Ophthalmic Surgeon (Cataract and Refractive Surgery), Ophthalmological Institute of Athens (OMMA)

2013-Present

Private Ophthalmic Clinic, Ramza Diamanti, MD, MRCOphth I, FEBO

Read more….

12/2009-01/2013

Registrar in Ophthalmology, General Hospital of Athens LAIKO

10/2007-12/2009

ΚClinical Fellow in Medical Retina, Ophthalmological Institute of Athens (OMMA)

02/2007-07/2007

Senior House Officer in Ophthalmology, Eye Treatment Centre, West Suffolk Hospital, Cambridge University Teaching Hospitals Trust

08/2006-02/2007

Senior House Officer in Ophthalmology, Eye Clinic, Furness General Hospital, University Hospitals of Morecambe Bay

03/2006-06/2006

Honorary Clinical Fellow, Eye Treatment Centre, West Suffolk Hospital, Cambridge University Teaching Hospitals Trust

02/2005-03/2006

Senior House Officer, Accident and Emergency Medicine (Community Service), DGH of Mytiline Vostanio, Lesvos- Greece

11/2004-02/2005

Senior House Officer, Rotation in Gen. Medicine, Gen. Surgery and Cardiology, DGH of Mytiline Vostanio, Lesvos-Greece

08/2003-07/2004

House Officer, Rotation in Athens University teaching hospitals (Medicine, General Surgery, Paediatrics, Obstetrics & Gynaecology, Psychiatry, Forensics)

CLINICAL EXPERIENCE

Surgical-Interventional Procedures

Therapeutic

  • Laser (Yag iridotomy, Yag capsulotomy, Argon laser conventional and Pascal, Iridoplasty, micropulse, PTK)
  • SLT (Selective Laser Trabeculoplasty)

Diagnostic

  • OCT /Angio-OCT 
  • CT (Corneal Topography-Placido, Pentacam) use and diagnosis
  • Fluorescein and Indocyanine Angiography (high-speed ICG) use and diagnosis

HONORS/AWARDS

Medical

  • 2004  Graduation Rank #5 – National and Kapodistrian University of Athens Medical School (aggregate years of study, out of 680 students)      
  • 2003-2004 Rank #1 in Year 6 – National and Kapodistrian University of Athens Medical School (for all studies in Year 6, average 93% -Grade A)
  • 2001-2004 Scholarship Distinction – National and Kapodistrian University of Athens Medical School (Years 4, 5, and 6 for overall academic achievement)

Academics

  • 1991-1997 Distinctions and Honors, Greek Ministry of Education – six consecutive years in Secondary and High School

Athletics

  • 2019 Greek Masters Track/Field Championship
    • Silver Medal, Long Jump
  •  Balkan Masters Indoor Track/Field Championships, Istanbul
    • Gold Medal, Long Jump
  • 2018 Balkan Masters Indoor Track/Field Championships, Belgrade
    • Gold Medal, Long Jump
  • 2017 Balkan Masters Indoor Track/Field Championships, Stara Zagora
    • Gold Medal, 4x100m relay (New Panhellenic Record)
    • Gold Medal, Long Jump
    • Gold Medal, Triple Jump
  •  Panhellenic Veterans Track/Field Championships
    • Gold Medal, Long Jump
    • Gold Medal, Triple Jump
  • 1993 Greek National Track/Field Champion, Long Jump
  • 1988-1997 Track/Field, National Distinction, Long Jump (10 consecutive years)

MEMBERSHIPS

  • American Academy of Ophthalmology (AAO)
  • Hellenic Ophthalmological Society
  • Hellenic Society of Intraocular Implant and Refractive Surgery
  • European Society of Cataract & Refractive Surgeons (ESCRS)
  • American Society of Cataract and Refractive Surgery (ASCRS)
  • American European Congress of Ophthalmic Surgery (AECOS)

OMMA Congress, December 2024

OMMA Congress, December 2023

OMMA Congress, December 2022

OMMA Congress, December 2021

OMMA Congress, December 2020

  • Presbyopia Correction A-Z, 3rd Argos & IOLs Masterclass, Bahrain, 2026
  • Pioneer Innovations in Cataract Surgery, OMMA Congress-Latest Advances in Ophthalmology, Athens, 2025
  • The Clareon Journey, from Clarity to Completeness, Saudi Ophthalmology Conference, Riyadh 2025
  • Premium Lenses change the era for cataract surgery, SRO, Sinaia, Romania 202
  • Presenting the benefits of an enhanced trifocal IOL for Presbyopia Management (clinical cases), Ophthaxchange Event by Alcon, Athens, Greece 2025
  • Presbyopia Patient Awareness Campaign, Sperses, Greece 2025
  • Fan Club Cataract & Refractive Surgery, 58th Panhellenic Ophthalmological Congress, Ilis Greece, 2025
  • Unsatisfactory outcome after IOL implantation: When the culprit is the Residual Refractive Error, AICCER, Trieste Italy 2025
  • Advanced Technology IOL: Novel Technologies to improve near vision, AICCER, Trieste Italy 2025
  • Correcting Presbyopia with Lens Surgery: How to do it and what are the achievable results. Let’s see clearly: which IOLs will we use in the near future?, AICCER, Trieste Italy 2025
Read More
  • Presbyopia Correction A-Z, 3rd Argos & IOLs Masterclass, Bahrain, 2026
  • Beyond surgery-Making the right choice for every patient, SRO Sinaia, Romania 2025
  • EU R & D CORE Cataract Advisory Board at ESCRS, Copenhagen September 2025
  • Advanced cataract and presbyopia, Barcelona June 2025
  • Tarsus Global Advisory Board on Demodex Blepharitis, ASCRS, Los Angeles April 2025
  • Advanced cataract and presbyopia, Barcelona March 2025
  • Advanced cataract and presbyopia, Barcelona November 2024 
  • 1st  European Core Cataract Advisory Board, Barcelona 2024
  •  Advanced cataract and presbyopia, Barcelona March 2024 
  •  Phaco for beginners, basic steps, HSIOIRS, Athens 2024
  •  Vivity Seminar for Japanese ophthalmic surgeons,  ESCRS, Vienna 2023
  •   Cataract Complication management, Barcelona June 2023
  •   Cataract Complication management, Barcelona March 2023
  • Broken Posterior Capsule, the sinking nucleus and the dangling IOL: Vitrectomy by the anterior segment surgeon, HSIOIRS, Athens March 2023    
  • Converting Patients to PCIOLs, COR Symposium, Helsinki November 2022
  • Advanced Cataract Refractive Cataract Surgery- Presbyopia Correction & Practice
  • Development, Alcon Experience Center, Barcelona October 2022
  • Intermediate Cataract,Alcon Experience Center, Barcelona June 2022
  • Advanced Cataract Refractive Cataract Surgery- Presbyopia Correction & Practice     Development, Alcon Experience Center, Barcelona May 2022
  • 2025
    • OMMA Congress-Latest advances in Ophthalmology, Athens
    • European Society of Cataract and Refractive Surgery, Copenhagen
    • American Society of Cataract and Refractive Surgery, Los Angeles
    • 29th Winter Conference of the European Society of Cataract and Refractive Surgery, Athens
  • 2024
    • OMMA Congress-Latest advances in Ophthalmology, Athens
    • European Society of Cataract and Refractive Surgery, Barcelona
    • American Society of Cataract and Refractive Surgery, Boston
    • 57th Pan-Hellenic Ophthalmological Congress, Thessaloniki
    • 38th  International Congress of the Hellenic Society of Intraocular Implant and Refractive Surgery, Athens
  • 2023
    • OMMA Congress-Latest advances in Ophthalmology, Athens
    • 10th EPOMEC, Dubai 
    • 18th Croatian Organization for Cataract and Refractive Surgery Symposium, Zadar Croatia
    • European Society of Cataract and Refractive Surgery, Vienna
    • 56th Pan-hellenic Ophthalmological Congress, Ioannina
Read More
  • Findl O, Fernández J, Diamanti R, Khoramnia R, Kretz F, Carones, Integrating presbyopia-correction into the everyday cataract practice, Eurotimes Jan-Feb 2025
  • Karageorgiou G, Petrou P, Kandarakis S, Rouvas A, Georgalas I, Datseris I, Diamanti R, Papakonstantinou E, Karamaounas A, Datseris I. ANTI-VEGF with PDT VS ANTI-VEGF with MICROPULSE laser for POLYPOIDAL CHOROIDAL VASCULOPATHY: A 12-month retrospective observational study, RETINA The Journal of Retinal and Vitreous Diseases
  • PhD Candidate 2020-2023: Aflibercept intravitreal injection effect on Polypoidal  Choroidal Vasculopathy as monotherapy and in combination with low fluence photodynamic therapy (LF-pdt).
  • Stefanickova J, Cunha-Vaz J, Ulbig M, Pearce I, Fernández-Vega Sanz A, Theodossiadis P, Kodjikian L, Izmailov A Muston D, Vassilev Z, Lamotte B, Tückmantel C, Friedl S, Altemark A, Schwarz HJ, Katz T; POLARIS study investigators. (2018). A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS). Acta Ophthalmol. 96(8):942-949
  • Thrapsanioti Z, Askounis P, Datseris I, Diamanti R, Papathanasiou M, Carinou E. (2017). Eye Lens Radiation Exposure in Greek Interventional Cardiology Article. Radiat Prot Dosimetry 175(3):344-356
  • Liaska A, Petrou P, Georgakopoulos C, Diamanti R, Papaconstantinou D, Kanakis M, and Georgalas I. (2016). β-Thalassemia and ocular implications: a systematic review. BMC Ophthalmol 8(16):102.
  • Ioannis Datseris I, Kontadakis G, Diamanti R, Pallikaris I, Theodossiadis P, and Tsilimbaris M. (2015). Prospective comparison of low-fluence photodynamic therapy combined intravitreal bevacizumab versus bevacizumab monotherapy for choroidal neovascularization in age-related macular degeneration. Semin Ophthalmol 30(2):112-117.
  • Rouvas A, ChatziralliI, Ladas I, Xanthopoulou V, Giannakaki E, Karamboula A, Galanis D, Datseris I, Alonistioti D, Diamanti R, Tsilimbaris M, Chalkia A, Theodossiadis P. (2014). The impact of financial crisis on central serous chorioretinopathy in Greece: is there any correlation? Eur J Ophthalmol 24(4):559-565
  • Evaluating Investigator, RETAIN Study: (2012). A 2-year randomized, single-masked, multicenter, controlled phase IIIb trial assessing th.e efficacy and safety of 0.5 mg ranibizumab in two “treat and extend” Treatment algorithms vs. 0.5 mg ranibizumab as needed in patients with macular oedema and visual impairment secondary to Diabetes Mellitus.